BRCA2 and head and neck squamous cell carcinoma: While both genes were expressed at a higher level in the blood of HNSCC patients compared to that of corresponding controls, a trend of decline in expression of both BRCA2 and XPD from stage II through stage IV was observed, mirroring the expression pattern observed in the tumour tissue, in both cases.